The AACP Bylaws direct the Bylaws and Policy Development Committee (BPDC) to ensure that resolutions, position papers, and similar proposals to the House of Delegates that seek to establish Association policy or action are appropriate and ready for consideration by the House. The Committee is also charged with responsibility for receiving suggestions for alteration of the Association's Articles of Incorporation or the Bylaws from any source, preparing appropriate amendments in suitable wording that is consistent with the current Bylaws, and for presenting such proposals, together with the Committee's recommendations, to the House of Delegates for consideration.
In 2005-06, AACP President Beck also charged the Bylaws and Policy Development Committee with analyzing AACP's voluntary leadership structure and governance systems and to propose changes, as appropriate, such that those systems engaged members effectively and helped to advance accomplishment of the AACP strategic plan. President Speedie asked the 2006-07 BPDC to continue and complete the structure and governance analysis.
A. RESOLUTIONSThe Bylaws and Policy Development Committee recommends adoption of all five (5) membership resolutions.
Resolution 1 – East Tennessee State UniversityRESOLVED that the East Tennessee State University School of Pharmacy be received into the appropriate level of institutional membership in AACP.
RESOLVED that the Northeastern Ohio Universities College of Pharmacy be received into the appropriate level of institutional membership in AACP.
RESOLVED that the Texas A&M Health Science Center Irma Lerma Rangel College of Pharmacy be received into the appropriate level of institutional membership in AACP.
RESOLVED that the Wegman St John Fisher College of Pharmacy be received into the appropriate level of institutional membership in AACP.
RESOLVED that the University of Hawaii – Hilo College of Pharmacy be received into the appropriate level of institutional membership in AACP.
The Bylaws and Policy Development Committee recommends referral of this policy statement to the appropriate body within the Association for further study.
THEREFORE be it resolved that:The American Association of Colleges of Pharmacy supports the position that by the year 2020, the completion of a PGY 1 accredited residency program should be a requirement for all new pharmacy school graduates who will be providing direct patient care.
Respectfully submitted by the following members of the American Association of Colleges of Pharmacy:
Stuart T. Haines, PharmD, FCCP, BCPS, University of Maryland
Jill Burkiewicz, PharmD, BCPS, Midwestern University, Chicago
Joseph T. DiPiro, PharmD, FCCP, South Carolina College of Pharmacy
Gary R. Matzke, PharmD, FCCP, Virginia Commonwealth University
Joseph Saseen, Pharm.D, FCCP, BCPS, University of Colorado
C. Edwin Webb, Pharm.D, MPH, American College of Clinical Pharmacy
The Bylaws and Policy Development Committee recommends adoption of amended language for the Oath of the Pharmacist.
I promise to devote myself to a lifetime of service to others through the profession of pharmacy.
In fulfilling this vow:
I will consider the welfare of humanity and relief of suffering my primary concerns.
I will apply my knowledge, experience, and skills to the best of my ability to assure optimal outcomes for my patients.
I will respect and protect all personal and health information entrusted to me.
I accept the lifelong obligation to improve my professional knowledge and competence.
I will hold myself and my colleagues to the highest principles of moral, ethical and legal conduct.
I will embrace and advocate changes that improve patient care.
I will utilize my knowledge, skills, experiences, and values to fulfill my obligation to educate and train the next generation of pharmacists.
I take these vows voluntarily with the full realization of the responsibility with which I am entrusted by the public.”
Respectfully submitted by the following members of the American Association of Colleges of Pharmacy Professionalism Committee Members:
Michelle R. Easton, PharmD, University of Charleston School of Pharmacy
Gireesh V. Gupchup, PhD, Southern Illinois University-Edwardsville School of Pharmacy
Paul W. Jungnickel, PhD, RPh, Auburn University Harrison School of Pharmacy
Lori J. Morin, MBA, University of Montana Skaggs School of Pharmacy
Andrea L. Smesny, MPH, PharmD, RPh, University of Houston College of Pharmacy
The Bylaws and Policy Development Committee recommends referral of this resolution to the AACP Board of Directors and Council of Faculties Task Force on Interprofessional Education.
The AACP section of Teachers of Pharmacy Practice recommends that the Association develop resources to assist faculty in promoting their inter-professional education and developing inter-professional courses and experiences at their schools and colleges.
Resolution 9 – Pharmacy Practice ResolutionThe Bylaws and Policy Development Committee recommends referral of this resolution to the AACP Board of Directors and to the leadership of all governance units of the Association for implementation.
The AACP section of Teachers of Pharmacy Practice recommends and supports efforts to address the shortage of Pharmacy Practice Faculty by providing resources on recruitment, rewards and retention systems.
Resolution 10 – Resolution from the Section of Teachers of ChemistryThe Bylaws and Policy Development Committee recommends referral of this resolution to the AACP Board of Directors for consideration and action.
Therefore, be it resolved that the AACP leadership, including the Board of Directors and the Executive Vice President, identify mechanisms to visibly and publicly affirm that medicinal chemistry is an essential component of the professional education of contemporary practitioners, and
Be it further resolved that the AACP leadership communicate to the Accreditation Council for Pharmacy Education (ACPE) its expectation that any School or College of Pharmacy that fails to incorporate medicinal chemistry or any other essential discipline into their required professional curriculum will be viewed as non-compliant with Standards 2007, and
Be it further resolved that the AACP leadership also communicate to ACPE its expectation that medicinal chemistry offered within the professional program of all Schools and Colleges of Pharmacy will be taught by faculty with the required academic expertise in this essential discipline.
Resolution 11 – COF ResolutionThe Council of Faculties leadership clarified that they had not intended that this resolution be forwarded to the House for action and therefore no action is needed.
Therefore be it resolved that the AACP Council of Faculties supports the concept of ensuring pharmacy students in schools of pharmacy receive education in medicinal chemistry by faculty with expertise in the discipline.
Resolution 12 – COD ResolutionThe Bylaws and Policy Development Committee recognized that this issue is consistent with the charge for the Academic Affairs Committee and recommends referral of this resolution to the AACP Board of Directors for consideration.
AACP develop a standing committee of the Association with a mission to facilitate the growth and development of postgraduate residencies and fellowships in member schools and colleges through academic sponsored and/or affiliated programs to meet the future practice faculty needs and support the initiatives of the profession.
B. PROPOSED POLICY STATEMENTSRegarding the AACP Standing Committees and Argus Commission reports:
Policy Recommendation 1: Mission of Pharmacy Education (Academic Affairs)The Bylaws and Policy Development Committee recommends adoption of an amended statement of policy.
The mission of pharmacy education is to prepare graduates who provide patient-centered care that ensures optimal medication therapy outcomes and provides a foundation for specialization in specific areas of pharmacy practice; participation in the education of patients, other healthcare providers, and future pharmacists; conduct of research and other scholarly activity; and provision of service and leadership to the community.
Policy Recommendation 2: Safe Medication Practices (Argus Commission)The Bylaws and Policy Development Committee recommends adoption of this policy statement.
AACP supports research, education, and development of practice models to promote safe medication practices as the standard of care in all practice settings.
Policy Recommendation 3: Educating Clinical Scientists (Educating Clinical Scientists Task Force)The Bylaws and Policy Development Committee recommends adoption of an amended statement of policy.
AACP encourages research intensive university pharmacy programs associated with academic health centers (AHCs) to accept as a necessary component of their research/graduate training mission, a significant interdisciplinary education/training program for clinical scientists in experimental pharmacotherapeutics at the PhD level.
Policy Recommendation 4: Interprofessional Education (Professional Affairs)The Bylaws and Policy Development Committee recommends adoption of this policy statement.
AACP endorses the competencies of the Institute of Medicine for health professions education and advocates that all colleges and schools of pharmacy provide faculty and students meaningful opportunities to engage in interprofessional education, practice and research to better meet health needs of society.
C. BYLAWSThe Bylaws and Policy Development Committee recommends adoption of this proposal to amend the AACP Bylaws.
The AACP Board of Directors proposes that Article III SECTION 1 C be struck from the current Bylaws which would eliminate the Affiliate Institutional level of membership in AACP.
Proposed Bylaws Amendment 2 (Council of Sections)The Bylaws and Policy Development Committee recommends creation of a Council of Sections whose leadership will be comprised of the elected leaders of the AACP Sections. The Chair-elect, Chair, and Immediate Past Chair of the Council of Sections will serve on the AACP Board of Directors.
Proposed Bylaws Amendment 3 (Special Interest Groups)The Bylaws and Policy Development Committee recommends retention of the term Special Interest Group and modification of Article V. Section 6 of the AACP Bylaws to form a SIG Cabinet.
Committee Members:
John Pieper (New Mexico), chair
Jeffrey Baldwin (Nebraska)
Rodney Carter (Minnesota)
Sudip Das (Butler)
Robert Drobitch (Lake Erie)
Stephen Gross (A&M Schwartz)
Barbara Hayes (Texas Southern)